Matthew Patterson
2016
In 2016, Matthew Patterson earned a total compensation of $648.8K as President, Chief Executive Officer and Director at Audentes Therapeutics, a 65% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $207,000 |
|---|---|
| Salary | $441,760 |
| Total | $648,760 |
Patterson received $441.8K in salary, accounting for 68% of the total pay in 2016.
Patterson also received $207K in non-equity incentive plan.
Rankings
In 2016, Matthew Patterson's compensation ranked 10,211th out of 14,075 executives tracked by ExecPay. In other words, Patterson earned more than 27.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,211 out of 14,075 | 28th |
Division Manufacturing | 3,947 out of 5,486 | 28th |
Major group Chemicals And Allied Products | 1,389 out of 1,900 | 27th |
Industry group Drugs | 1,110 out of 1,543 | 28th |
Industry Biological Products, Except Diagnostic Substances | 194 out of 287 | 32nd |
Source: SEC filing on April 27, 2017.
Patterson's colleagues
We found three more compensation records of executives who worked with Matthew Patterson at Audentes Therapeutics in 2016.